News und Analysen
DGAP-News: Abivax verschiebt seine ordentliche Hauptversammlung auf den 19. Juni 2020
DGAP-News: Abivax verschiebt seine ordentliche Hauptversammlung auf den 19. Juni 2020
DGAP-News: Abivax postpones its Annual General Meeting to June 19, 2020
DGAP-News: Abivax postpones its Annual General Meeting to June 19, 2020
Showroomprive.com: Availability of shareholders' meeting documents
Showroomprive.com: Availability of shareholders' meeting documents
DGAP-News: ABIVAX: €36 million non-dilutive funding from Bpifrance for Abivax' ABX464 Covid-19 program
DGAP-News: ABIVAX: €36 million non-dilutive funding from Bpifrance for Abivax' ABX464 Covid-19 program
DGAP-News: ABIVAX: €36 millionen nicht-verwässernde Finanzierung von Bpifrance für Abivax' ABX464 Covid-19-Programm
DGAP-News: ABIVAX: €36 millionen nicht-verwässernde Finanzierung von Bpifrance für Abivax' ABX464 Covid-19-Programm
Voltalia includes a purpose in its articles of incorporation
Voltalia includes a purpose in its articles of incorporation
DGAP-News: ABX464 hemmt die Replikation von SARS-CoV-2 (COVID-19) im rekonstituierten humanen Atemwegsepithelmodell
DGAP-News: ABX464 hemmt die Replikation von SARS-CoV-2 (COVID-19) im rekonstituierten humanen Atemwegsepithelmodell
DGAP-News: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
DGAP-News: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
DGAP-News: Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
DGAP-News: Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
DGAP-News: Abivax erhält Genehmigung der ANSM und der Ethikkommission zur Testung seines Entwicklungskandidaten ABX464 in einer randomisierten Phase-2b/3-Studie mit 1.034 Covid-19-Patienten
DGAP-News: Abivax erhält Genehmigung der ANSM und der Ethikkommission zur Testung seines Entwicklungskandidaten ABX464 in einer randomisierten Phase-2b/3-Studie mit 1.034 Covid-19-Patienten
Kaufman & Broad SA: Dividend payment in respect of the financial year ended november 30 2019
Kaufman & Broad SA: Dividend payment in respect of the financial year ended november 30 2019
Kaufman & Broad SA: COMBINED ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING MAY 5, 2020
Kaufman & Broad SA: COMBINED ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING MAY 5, 2020
Showroomprive.com:Q1 2020 net revenues: €118.2m Measured decline - sensitive rebound of activity in April
Showroomprive.com:Q1 2020 net revenues: €118.2m Measured decline - sensitive rebound of activity in April
Kaufman & Broad SA: DESCRIPTION OF THE SHARE REPURCHASE PROGRAM
Kaufman & Broad SA: DESCRIPTION OF THE SHARE REPURCHASE PROGRAM
Showroomprive.com: PUBLICATION OF THE 2019 UNIVERSAL REGISTRATION DOCUMENT, INCLUDING THE 2019 AUDITED CONSOLIDATED FINANCIAL STATEMENTS
Showroomprive.com: PUBLICATION OF THE 2019 UNIVERSAL REGISTRATION DOCUMENT, INCLUDING THE 2019 AUDITED CONSOLIDATED FINANCIAL STATEMENTS
Showroomprive.com: SHORT AND MEDIUM-TERM FINANCIAL STRUCTURE STRENGTHENED
Showroomprive.com: SHORT AND MEDIUM-TERM FINANCIAL STRUCTURE STRENGTHENED
DGAP-News: Abivax verschiebt Veröffentlichung des Referenzdokuments ('Universal Registration Document', URD)
DGAP-News: Abivax verschiebt Veröffentlichung des Referenzdokuments ('Universal Registration Document', URD)
DGAP-News: Abivax postpones the publication of the yearly universal registration document ('URD')
DGAP-News: Abivax postpones the publication of the yearly universal registration document ('URD')
Voltalia buys Nordex turbines for its new VSM 4 wind farm of 59 megawatts in Brazil
Voltalia buys Nordex turbines for its new VSM 4 wind farm of 59 megawatts in Brazil
Voltalia SA: Availability of the preparatory documents for the General Meeting of shareholders, to be held in camera without the physical attendance of the shareholders. The presentation (in French) will be webcast on the company's website.
Voltalia SA: Availability of the preparatory documents for the General Meeting of shareholders, to be held in camera without the physical attendance of the shareholders. The presentation (in French) will be webcast on the company's website.
Voltalia SA: Q1 2020 revenue growth of 47%, at constant currency - Ambitions maintained, in a less predictable environment
Voltalia SA: Q1 2020 revenue growth of 47%, at constant currency - Ambitions maintained, in a less predictable environment
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2019 ACCOUNTS
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2019 ACCOUNTS
Voltalia SA: total number of shares and voting rights in the share capital as of March 31, 2020
Voltalia SA: total number of shares and voting rights in the share capital as of March 31, 2020
Kaufman & Broad SA: Downward adjustement of dividend amount for 2019
Kaufman & Broad SA: Downward adjustement of dividend amount for 2019